Four Neurodegenerations: One Mechanism
Alzheimer's, multiple sclerosis, Parkinson's, and ALS each attack a different cell type through Ca²⁺-dependent mechanisms. Each has pharmacological validation through Ca²⁺-targeting drugs. Same cascade, four manifestations.
This page presents the Ca²⁺ connection across four neurodegenerative diseases. Each disease's Ca²⁺ mechanism is independently established. The unifying EMF connection remains a BERM hypothesis.
The four diseases
Alzheimer’s disease
Cell type: Hippocampus / cortex
Ca²⁺ mechanism: PGC + cortisol↑ + melatonin↓. Intracellular Ca²⁺ dysregulation is an EARLY event preceding amyloid accumulation. Ca²⁺ directs Aβ into toxic oligomers rather than harmless fibrils.
BERM connection: VK14 (cortisol→hippocampus), VK3 (PGC→melatonin), S6
Protective drug: Semaglutide (GLP-1R→Ca²⁺), melatonin
Multiple sclerosis
Cell type: OPC / myelin
Ca²⁺ mechanism: Cav1.2 → OPC differentiation → myelination. L-type VGCC activity is required for oligodendrocyte precursor cells to differentiate and form myelin sheaths. Disrupted Cav1.2 timing → myelination failure.
BERM connection: VK20
Protective drug: — (but EMF-induced Cav1.2 dysregulation → myelination timing disruption)
Parkinson’s disease
Cell type: SNpc DA neurons
Ca²⁺ mechanism: Cav1.3 → pacemaker activity. Cav1.3 drives autonomous pacemaking in substantia nigra pars compacta dopaminergic neurons. Ca²⁺ overload → mitochondrial stress → selective neuronal death.
BERM connection: Cav1.3 drives autonomous pacemaking in SNpc neurons; Ca²⁺ overload → mitochondrial stress → death
Protective drug: Isradipine (Cav1.3 blocker, neuroprotective in animal models)
ALS
Cell type: Motor neurons
Ca²⁺ mechanism: Low Ca²⁺ buffering + Ca²⁺-permeable AMPA receptors. Motor neurons have unusually low calcium-buffering capacity, making them selectively vulnerable to Ca²⁺-permeable AMPA receptor activation.
BERM connection: VK45
Protective drug: Riluzole (indirect — Na⁺ block → glutamate↓ → Ca²⁺↓)
Occupational data: Electrical workers OR 1.3–1.7
Common thread
All four diseases involve Ca²⁺ overload in specific cell types
Each cell type has unique vulnerability: hippocampal neurons to cortisol-driven Ca²⁺, OPCs to Cav1.2 timing, SNpc neurons to Cav1.3 pacemaker load, motor neurons to AMPA-mediated Ca²⁺
Pharmacological validation: drugs targeting the Ca²⁺ mechanism show benefit in each disease
EMF provides a common environmental driver through the VGCC pathway
Different cell types, same mechanism
| Disease | Cell Type | Ca²⁺ Mechanism | Protective Drug |
|---|---|---|---|
| Alzheimer’s | Hippocampus / cortex | PGC + cortisol↑ + melatonin↓ | Semaglutide, melatonin |
| Multiple sclerosis | OPC / myelin | Cav1.2 → OPC differentiation | — |
| Parkinson’s | SNpc DA neurons | Cav1.3 pacemaker overload | Isradipine |
| ALS | Motor neurons | Low buffering + Ca²⁺-permeable AMPA | Riluzole (indirect) |
Derived prediction · L* level
This section describes predictions derived from the BERM framework that have not yet been directly tested. They are presented as testable hypotheses, not established findings.
Prediction E-NEW-25: ALS incidence is elevated in occupations with high EMF exposure. Electrical workers show OR 1.3–1.7 for ALS across multiple epidemiological studies.
See predictions →